These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1401280)

  • 1. Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis. An assessment of clinical significance when viewed as a risk factor for cardiovascular disease.
    Stiller MJ; Pak GH; Kenny C; Jondreau L; Davis I; Wachsman S; Shupack JL
    J Am Acad Dermatol; 1992 Sep; 27(3):434-8. PubMed ID: 1401280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure.
    Lowe NJ; Wieder JM; Rosenbach A; Johnson K; Kunkel R; Bainbridge C; Bourget T; Dimov I; Simpson K; Glass E; Grabie MT
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):710-9. PubMed ID: 8912566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridemia in patients with psoriasis treated with cyclosporine.
    Grossman RM; Delaney RJ; Brinton EA; Carter DM; Gottlieb AB
    J Am Acad Dermatol; 1991 Oct; 25(4):648-51. PubMed ID: 1791223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in renal function in psoriasis patients treated with cyclosporine, 5 mg/kg/day.
    Margolis DJ; Guzzo C; Johnson J; Lazarus GS
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):195-7. PubMed ID: 1552052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia in children: the role of uremia, steroids and cyclosporine therapy.
    Singh A; Tejani A
    Nephron; 1996; 74(3):529-35. PubMed ID: 8938676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial.
    Ellis CN; Fradin MS; Messana JM; Brown MD; Siegel MT; Hartley AH; Rocher LL; Wheeler S; Hamilton TA; Parish TG
    N Engl J Med; 1991 Jan; 324(5):277-84. PubMed ID: 1986287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.
    Ho VC; Griffiths CE; Berth-Jones J; Papp KA; Vanaclocha F; Dauden E; Beard A; Puvanarajan L; Paul C
    J Am Acad Dermatol; 2001 Apr; 44(4):643-51. PubMed ID: 11260540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged cyclosporine treatment of severe or recalcitrant psoriasis: descriptive study in a series of 20 patients.
    Borghi A; Corazza M; Mantovani L; Bertoldi AM; Giari S; Virgili A
    Int J Dermatol; 2012 Dec; 51(12):1512-6. PubMed ID: 23171021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine as maintenance therapy in patients with severe psoriasis.
    Shupack J; Abel E; Bauer E; Brown M; Drake L; Freinkel R; Guzzo C; Koo J; Levine N; Lowe N; McDonald C; Margolis D; Stiller M; Wintroub B; Bainbridge C; Evans S; Hilss S; Mietlowski W; Winslow C; Birnbaum JE
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):423-32. PubMed ID: 9091474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients.
    Manzarbeitia C; Reich DJ; Rothstein KD; Braitman LE; Levin S; Munoz SJ
    Liver Transpl; 2001 Feb; 7(2):93-9. PubMed ID: 11172391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
    Heydendael VM; Spuls PI; Opmeer BC; de Borgie CA; Reitsma JB; Goldschmidt WF; Bossuyt PM; Bos JD; de Rie MA
    N Engl J Med; 2003 Aug; 349(7):658-65. PubMed ID: 12917302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: results of a multicenter study. German Multicenter Study.
    Mrowietz U; Färber L; Henneicke-von Zepelin HH; Bachmann H; Welzel D; Christophers E
    J Am Acad Dermatol; 1995 Sep; 33(3):470-5. PubMed ID: 7657870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
    Keiser PH; Sension MG; DeJesus E; Rodriguez A; Olliffe JF; Williams VC; Wakeford JH; Snidow JW; Shachoy-Clark AD; Fleming JW; Pakes GE; Hernandez JE;
    BMC Infect Dis; 2005 Jan; 5():2. PubMed ID: 15647105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis. The German Multicenter Study.
    Christophers E; Mrowietz U; Henneicke HH; Färber L; Welzel D
    J Am Acad Dermatol; 1992 Jan; 26(1):86-90. PubMed ID: 1732342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
    Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients.
    Faerber L; Braeutigam M; Weidinger G; Mrowietz U; Christophers E; Schulze HJ; Mahrle G; Meffert H; Drechsler S
    Am J Clin Dermatol; 2001; 2(1):41-7. PubMed ID: 11702620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3.
    Egeberg A; Wu JJ; Korman N; Solomon JA; Goldblum O; Zhao F; Mallbris L
    J Am Acad Dermatol; 2018 Jul; 79(1):104-109.e8. PubMed ID: 29548945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine therapy for psoriasis: a cell cycle-derived dosing schedule.
    Goodman MM; White GM; McCormick A; McCullough J; Weinstein G
    J Am Acad Dermatol; 1992 Oct; 27(4):594-8. PubMed ID: 1401311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis.
    Laburte C; Grossman R; Abi-Rached J; Abeywickrama KH; Dubertret L
    Br J Dermatol; 1994 Mar; 130(3):366-75. PubMed ID: 8148280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.